Electra Ltd ELTR

Electra today announced it successfully completed first-of-its-kind flights from a heliport on a commercial airport ramp at the Roanoke–Blacksburg Regional Airport. The operations showcased the breakthrough capabilities of Electra's fixed-wing Ultra Short aircraft to use vertical flight landing areas and helicopter-style instrument procedures to support reliable, affordable, and safe regional operations without adding traffic to congested airport runways.

Electra Battery Materials Corporation (ELBM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Singapore, Singapore, Sept. 19, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics offers 21.7 million shares at $14 to $16 each on the Nasdaq Global Select Market, with proceeds carrying the antibody ipsoprubart through its SURPASS registration trial in a rare and frequently fatal immune disorder. Electra Therapeutics sets terms for a Nasdaq listing that carries the clinical-stage antibody developer to the edge of a $1 billion valuation. The company sells 21.7 million shares at $14 to $16 each in a

Electra has delivered a solid share price run over the past few years, which naturally raises the question of whether the current tag is fully supported by its earnings. With the stock now around ₪114.2, investors are asking how much of that strength can be explained by the underlying profit engine rather than sentiment alone. Electra has returned about 60.8% over the past 3 years, which puts real weight on the question of whether its earnings now justify the higher starting point for new...

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer, today announced the pricing of its upsized initial public offering of 23,333,334 shares of common stock at a price to the public of $15.00 per share. The gross proceeds to Electra from the offering, before deducting underwriting discounts and co

Nearly a dozen biotechnology firms have matched or raised more than $300 million in their initial public offerings in 2026, a figure not seen since new stock sales peaked in 2021, according to BioPharma Dive data.

Electra Therapeutics is heading toward a Nasdaq listing with a promising clinical pipeline, a capital-intensive path ahead, and key milestones on investors’ radar.

Electra Battery Materials (ELBM.V, ELBM) received preliminary engineering results for the initial ph

Initial engineering evaluates 20,000 tonnes of annual nickel production as the first phase of a broader critical minerals processing facility TORONTO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), a leader in North American critical minerals processing, today announced preliminary engineering results for the initial phase of a proposed two-phase nickel refinery to process mine-derived feedstock and recycled batt

TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is eligible for an additional 180-calendar-day period, or until March 15, 2027 (the “Extension”), to regain compliance with Nasdaq’s $1.00 minimum bid price requirement (the “Minimum Bid Price Requirement”) for continued listing on Nasdaq. The Extension h

Electra likens its targeted approach in immune-mediated disease to what precision oncology has achieved in cancer.

Electra CEO Marc Allen to keynote; forum convenes manufacturers, federal regulators, defense leaders and investors at the country's only build-test-fly campusSPRINGFIELD, Ohio, Sept. 15, 2026 (GLOBE NEWSWIRE) -- The National Advanced Air Mobility Center of Excellence (NAAMCE) will host the fifth annual National Advanced Air Mobility Industry Forum (NAAMIF), sponsored by JobsOhio, on Oct. 15, bringing together aircraft manufacturers, federal regulators, military leaders, investors and infrastruct

Electra and The Atlas Group today announced a landmark airframe agreement for the EL9 Ultra Short airplane, pairing Electra's innovative aircraft design with Atlas's proven aerospace manufacturing expertise as the program advances through flight test, certification, and toward scaled commercial production.

Electra and Atlas today announced a landmark airframe agreement for the EL9 Ultra Short airplane, pairing Electra's innovative aircraft design with Atlas's proven aerospace manufacturing expertise as the program advances through flight test, certification, and toward scaled commercial production.

SOUTH SAN FRANCISCO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, a clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer, today announced the promotion of Chris Clark, CFA, to Chief Financial Officer. Mr. Clark joined Electra in December 2025 as Executive Vice President, Strategy and Finance, bringing with him more than two decades of life sciences investment experience. “Since joini

TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), a leader in advancing North America’s critical minerals processing, today announced is upcoming schedule of investor and industry engagement for September as the Company continues to advance construction of its Ontario cobalt sulfate refinery and its broader North American critical minerals strategy. Members of Electra’s executive leadership team will partic

TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) today announced that it has engaged Douglas Geniti as Senior Advisor, Commercial Strategy. Based in New York, Mr. Geniti will support Electra’s commercial planning as the Company advances construction of its North American cobalt sulfate refinery toward commissioning and production ramp-up in 2027. Mr. Geniti brings more than 35 years of experience across the